Long-term Follow-up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients With Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 4, 2014, Pages 644-650

  Selinger, Christian P ^a,b   Andrews, Jane M ^c   Titman, Andrew ^d   Norton, Ian ^e,h   Jones, D Brian ^a   McDonald, Charles ^a,h   Barr, Gavin ^a,h   Selby, Warwick ^a,f,h   Leong, Rupert ^h   Andrews, Jane ^h   Barnes, Phil ^h   Bye, William ^h   Chapman, Grace ^h   Cowlishaw, James ^h   Gallagher, Neil ^h   Gillies, Margaret ^h   Goulston, Kerry ^h   Goulston, Stanley ^h   Jones, Brian ^h   Kater, Rod ^h   Ngu, Meng ^h   Perkins, Kenneth ^h   more..

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d LANCASTER UNIVERSITY   (United Kingdom)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h NONE

Author keywords

Colon cancer risk; Prognosis; Therapy; Treatment

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; BIOLOGICAL THERAPY; CANCER PATIENT; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHILD; COHORT ANALYSIS; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; PRESCHOOL CHILD; SCHOOL CHILD; ULCERATIVE COLITIS; UNIVERSITY HOSPITAL; VERY ELDERLY; YOUNG ADULT;

COLON CANCER RISK; PROGNOSIS; THERAPY; TREATMENT;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84896094219     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.05.017     Document Type: Article

References (32)

1. Mowat C., Cole A., Windsor A., et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011, 60:571-607.
2. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
3. Jawad N., Direkze N., Leedham S.J. Inflammatory bowel disease and colon cancer. Recent Results Cancer Res 2011, 185:99-115.
4. Katsanos K.H., Tatsioni A., Pedersen N., et al. Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study. JCrohns Colitis 2011, 5:430-442.
5. Hou J.K., Kramer J.R., Richardson P., et al. Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis. Inflamm Bowel Dis 2012, 18:1011-1017.
6. Canavan C., Abrams K.R., Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006, 23:1097-1104.
7. Lémann M. Review article: can post-operative recurrence in Crohn's disease be prevented?. Aliment Pharmacol Ther 2006, 24(Suppl 3):22-28.
8. Uchino M., Ikeuchi H., Bando T., et al. Risk factors for short bowel syndrome in patients with Crohn's disease. Surg Today 2012, 42:447-452.
9. Carlsson E., Bosaeus I., Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr 2003, 22:445-452.
10. Egberts J.H., Stroeh A., Alkatout I., et al. Preoperative risk evaluation of postoperative morbidity in IBD patients: impact of the POSSUM score. Int J Colorectal Dis 2011, 26:783-792.
11. Stallmach A., Hagel S., Gharbi A., et al. Medical and surgical therapy of inflammatory bowel disease in the elderly: prospects and complications. JCrohns Colitis 2011, 5:177-188.
12. Andrews J.M., Norton I., Dent O., et al. Inflammatory bowel disease: a retrospective review of a specialist-based cohort. Med J Aust 1995, 163:133-136.
13. Selinger C.P., Andrews J., Dent O.F., et al. Cause specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitis. Inflammatory Bowel Diseases 2013, 19:1880-1888.
14. Fine J.P., Gray R.J. Aproportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association 1999, 94:496-509.
15. Gray R. Cause-specific cumulative incidence estimation and the Fine and Gray model under both left truncation and right censoring. Biometrics 2011, 67:39-49.
16. Moser G., Tillinger W., Sachs G., et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995, 7:853-858.
17. Sinclair T.S., Brunt P.W., Mowat N.A. Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology 1983, 85:1-11.
18. Tracey E, Kerr T, Dobrovic A, etal. Cancer in New South Wales: incidence and mortality report 2008. In: Health NSWDo. Sydney: Department of Health, 2010.
19. Cosnes J., Nion-Larmurier I., Beaugerie L., et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005, 54:237-241.
20. Ramadas A.V., Gunesh S., Thomas G.A., et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010, 59:1200-1206.
21. Winther K.V., Jess T., Langholz E., et al. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2004, 2:1088-1095.
22. Jess T., Loftus E.V., Velayos F.S., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota. Gastroenterology 2006, 130:1039-1046.
23. Lakatos L., Mester G., Erdelyi Z., et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 2006, 12:205-211.
24. Doubeni C.A., Laiyemo A.O., Major J.M., et al. Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study. Cancer 2012, 118:3636-3644.
25. Farmer R.G., Easley K.A., Rankin G.B. Clinical patterns, natural history, and progression of ulcerative colitis: a long-term follow-up of 1116 patients. Dig Dis Sci 1993, 38:1137-1146.
26. Leijonmarck C.E., Persson P.G., Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990, 31:329-333.
27. Langholz E., Munkholm P., Davidsen M., et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992, 103:1444-1451.
28. Höie O., Schouten L.J., Wolters F.L., et al. Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut 2007, 56:497-503.
29. Hoie O., Wolters F.L., Riis L., et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007, 132:507-515.
30. Krishnaprasad K., Andrews J.M., Lawrance I.C., et al. Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: how good are we? A multi-centre Australasian study. JCrohns Colitis 2012, 6:287-293.
31. Lakatos P.L., Golovics P.A., David G., et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from western Hungary between 1977-2009. Am J Gastroenterol 2012, 107:579-588.
32. Bernstein C.N., Loftus E.V., Ng S.C., et al. Hospitalisations and surgery in Crohn's disease. Gut 2012, 61:622-629.